TVTX · Travere Therapeutics, Inc.
Market Cap
$6.15B
Shares
94.26M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1438533
CUSIP
89422G107
13F (30d)
214 filings
213 filers
Visit website
Investor relations